To: The United States Environmental Protection Agency (EPA) Science Advisory Board (SAB)
"In conclusion, the Endocrine Society remains extremely concerned that the proposed rule Strengthening Transparency in Regulatory Science lacks transparency, is unclear about data utilization and modeling of low-dose effects, and fundamentally lacks justification. We anticipate that the rule in its current construction will result in harmful effects on public health. We commend the authors of the draft SAB report for carefully evaluating the proposed rule and calling into question not only the potential impact of the rule but also recognizing that the EPA “has not fully identified the problem to be addressed” by the rule. We encourage EPA to thoughtfully and carefully consider these and other important issues highlighted in the report."
Read the Full Letter
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.
